Blueprint Medicines Competitors and Similar CompaniesClear all
Blueprint Medicines's competitors and similar companies include Halozyme Therapeutics, Deciphera Pharmaceuticals, Repare Therapeutics, Ohm Oncology and AstraZeneca United States.
 Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. |  Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Repare Therapeutics Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. |  Ohm Oncology Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds. | ||
Founding Date | Founding Date 2011 | Founding Date 1998 | Founding Date 2003 | Founding Date 2016 | Founding Date 2015 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | ||||||
Locations | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations San Diego, US HQ | Locations Waltham, US HQ Lawrence, US | Locations Montréal, CA HQ Cambridge, US | Locations Austin, US HQ | Locations Wilmington, US HQ Gaithersburg, US |
Employees | Employees 49515% increase | Employees 1457% increase | Employees 35037% increase | Employees 180 | Employees 167% decrease | Employees N/A |
Valuation ($) | Valuation ($) 4.2 b | Valuation ($) 5.4 b | Valuation ($) 970.3 m | Valuation ($) 222.9 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 2.8 k | Twitter followers 423 | Twitter followers 783 | Twitter followers 1 k | Twitter followers N/A | Twitter followers 83.4 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 5 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.7 | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) 1.5 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 5.6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 88.89% | Percentage of tweets with engagement (last 30 days) 50% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 80% |
Employee Rating | Employee Rating 4.2 | Employee Rating 3.1 | Employee Rating 3.7 | Employee Rating 4.9 | Employee Rating N/A | Employee Rating N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $204m (FY, 2022) | Revenue (est.) $660.1m (FY, 2022) | Revenue (est.) $134m (FY, 2022) | Revenue (est.) $131.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $17.8m (FY, 2022) | Cost of goods $139.3m (FY, 2022) | Cost of goods $8.8m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $186.2m (FY, 2022) | Gross profit $520.8m (FY, 2022) | Gross profit $125.3m (FY, 2022) | Gross profit $131.8m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($557.5m) (FY, 2022) | Net income $202.1m (FY, 2022) | Net income ($178.9m) (FY, 2022) | Net income ($29m) (FY, 2022) | Net income N/A | Net income N/A |
Operating ⚠ | ||||||
Patent Applications | Patent Applications N/A | Patent Applications 50 (FY, 2020) | Patent Applications 49 (Aug, 2017) | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A |
Patents (US) | Patents (US) N/A | Patents (US) 43 (FY, 2020) | Patents (US) 11 (Aug, 2017) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 1.7b | Total funding raised $ 171.9m | Total funding raised $ 714m | Total funding raised $ 150.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
145↑ 7% increase
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyRepare Therapeutics
HQ
Montréal, CA
Employees
180
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
View companyOhm Oncology
HQ
Austin, US
Employees
1
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
View company